跳至主要内容
临床试验/NCT02876471
NCT02876471已完成不适用

Huai'an First People's Hospital,Nanjing Medical University

Huai'an No.1 People's Hospital1 个研究点 分布在 1 个国家目标入组 198 人开始时间: 2016年3月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
198
试验地点
1
主要终点
time of event

研究概览

简要总结

Emerging evidence suggests that there is a causal link between obstructive sleep apnea(OSA) and hypertension. Patient with this syndrome exhibit several characteristics: high prevalence, frequent non-dipper status, diastolic and nocturnal predominance, which are related to clinical and subclinical organ damage in heart and brain. However, the influence of OSA on nocturnal hypertension development has not yet been clarified. Blood pressure variability (BPV) plays a role in vascular damage, independent of blood pressure. Apnea overloads the autonomic cardiovascular control system and may influence BPV,which is classified by different time interval, including beat-to-beat, hour-to-hour day-to-night changes or long-term, for example days, weeks, months, seasons, and even years. All BPV abnormalities are associated with an increased incidence of cardiovascular events and mortality. The investigators pre-experiment estimate BPV by ambulatory blood pressure monitoring (ABPM), which unable to capture the BP fluctuation accurately during the apnea event. The small studies exam beat-to-beat BP and OSA,and the investigators can't couple the events with blood fluctuation, also incapable calculate the correlation of them. This study is aimed to use pulse transmit time(PTT) based blood pressure measurement which can be useful for continuous monitoring of blood pressure to monitor nocturnal beat-to-beat blood pressure fluctuation in OSA with or without hypertension, investigating the degree of relevance between hypoxia, AHI, nocturnal hypertension development and BPV. Besides that the investigators also evaluate the effect of continuous positive airway pressure(CPAP) on blood pressure and nocturnal beat-to-beat BPV.

详细描述

Methods:

Between March 2016 and December 2016,the investigators initially recruited 450 individuals reporting severe habitual snoring. Primal evaluations including office blood pressure, Epworth Sleepiness Scale Score(ESS), antihypertensive medicine demographic and anthropometric data. Then overnight polysomnography were performed. Of them,100 were severe OSA (AHI>30 episode/h) with hypertension, who were agreed to stop taking antihypertensive medicine. The investigators calculated the time to stop based on the half-life of patients taking oral drugs and last time administration time. The subject who withdrawal time was less than three days was enrolled in this study. These patients were hospitalized and close monitoring of blood pressure, for blood pressure three times greater than 180/110mmHg or appearing dizziness, headache and other clinical syndrome, the investigators will give a timely clinical intervention and get rid of this study. The control group consisted of 100 subjects just with severe OSA whose blood pressure is normal. The investigators recorded nocturnal blood pressure, oximetry, beat-to-beat BPV, AHI, BP event was calculated. Screening of 40 newly diagnosed patients with hypertension and subjects with poor blood pressure control, the investigators would give one-night continuous positive airway pressure(CPAP) to compare the AHI, the mean nocturnal systolic blood pressure and diastolic blood pressure, the number of blood events before and after short-term CPAP therapy, to compare the AHI, the mean nocturnal systolic blood pressure and diastolic blood pressure, the number of blood events before and after short-term CPAP therapy.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • severity OSA (AHI>30 episode/h)
  • aged between 18 to 70 yeas
  • blood pressure≦180/110mmHg

排除标准

  • blood pressure>180/110mmHg
  • severe clinical events such as coronary artery disease, heart failure,cerebrovascular disease or renal failure
  • patients with suspected secondary hypertension
  • patients with pulmonary disease being treated with bronchodilators, corticosteroids, or oxygen
  • individuals who are able to perform the test

结局指标

主要结局

time of event

时间窗: 1 night

as the total time of apnea and hypopnea during sleep

Office hypertension

时间窗: 2 hours

as BP≧140/90mmHg on three different occasions (according to standard guidelines)

BP event

时间窗: 1 night

the number of beat-to-beat BPV\>10mmHg divided by sleep time

Beat-to-Beat BPV

时间窗: 1 night

as the a increase in systolic blood pressure(SPB) from baseline during an apnea event

nocturnal hypertension

时间窗: 1 night

as nighttime systolic blood pressure ≧120mmHg and/or70mmHg(diastolic blood pressure)

hypoxemia

时间窗: 1 night

as the total time and the number of pulse oxygen less than 90% ,the minimum lowest pulse oxygen saturation during sleep

Apnea-hypopnea index(AHI)

时间窗: 1 night

AHI was defined as the number of apnea plus hypopnea episode per hour of sleep and was the summary measurement of the occurrence of sleep -disordered breathing.Apnea was defined as a reduction of airflow of at least 90% on the oronasal thermistor for at least 10s(it was considered obstructive if respiratory effort was absent).Hypopneas was scored when the magnitude of the signal decreased by at least 30% of the baseline amplitude of the nasal pressure transducer for at least 10s and was associated with a 4% or greater drop in oxygen saturation,as measured by finger pulse oximetry.

次要结局

未报告次要终点

研究者

发起方
Huai'an No.1 People's Hospital
申办方类型
Other
责任方
Principal Investigator
主要研究者

Xu J

Doctor of the sleep center in Huai'an NO.1People's Hospital

Huai'an No.1 People's Hospital

研究点 (1)

Loading locations...

相似试验